A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.
Servier
Servier
Ono Pharmaceutical Co. Ltd
Arcus Biosciences, Inc.
Jazz Pharmaceuticals
Arcus Biosciences, Inc.
Arcus Biosciences, Inc.
Seagen Inc.
Qurient Co., Ltd.
AstraZeneca
Merus B.V.
Amgen
Astellas Pharma Inc
Nouscom SRL
USWM, LLC (dba US WorldMeds)
Poseida Therapeutics, Inc.
Astellas Pharma Inc
Genentech, Inc.
Hoffmann-La Roche
Amgen
AstraZeneca
ImmunityBio, Inc.
TORL Biotherapeutics, LLC
Daiichi Sankyo
Amgen
Inhibrx Biosciences, Inc
Suzhou Transcenta Therapeutics Co., Ltd.
Amgen
Legend Biotech USA Inc
Amgen
HiFiBiO Therapeutics
HiFiBiO Therapeutics
BicycleTx Limited
SystImmune Inc.
Rottapharm Biotech
Astellas Pharma Inc
Turning Point Therapeutics, Inc.
RemeGen Co., Ltd.
AskGene Pharma, Inc.
Exelixis
ALX Oncology Inc.
Toray Industries, Inc
Bristol-Myers Squibb
CARsgen Therapeutics Co., Ltd.
Hutchmed
Tempus AI
Bristol-Myers Squibb
Cybrexa Therapeutics
CARsgen Therapeutics Co., Ltd.
Carisma Therapeutics Inc
Novomics. Co., Ltd.